Regeneron’s stock $REGN dipped about 4% on Tuesday following a loss in its legal battle with Amgen over competitors to its ...

Wave Life Sciences said new Phase 2 biomarker data for its exon-skipping therapy are promising for certain patients with ...

PCI Pharma Services is pouring $365 million to expand its US and Irish footprint for commercial and clinical packaging of ...

You win some, you lose some — that’s the risk of trying to predict the next hot biotechs. Since 2018, the Endpoints 11 awards ...

Biotech investment firm Samsara BioCapital has added three new venture partners in recent months to expand its network, ...

Sanofi has appointed Mike Quigley, a former executive at Gilead and Bristol Myers Squibb, as the French pharma's next chief ...

Metsera, the well-funded obesity biotech from Population Health Partners and ARCH Venture Partners, has unveiled its first ...

The US House of Representatives on Monday afternoon unanimously passed a wide-ranging bill via voice vote that will ...

Bluebird bio announced Tuesday morning that it is laying off 25% of its workforce and cutting expenses by 20%. The move comes ...

Centivo, a startup that sells health insurance to employers, raised $75 million in fresh funds months after it bought a ...

Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...

Biogen and UCB said Tuesday morning that data from a Phase 3 study for the lupus program dapirolizumab pegol were strong ...